During the past decade, Instituto de Ensino E Pesquisa Sao Lucas conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Ensino E Pesquisa Sao Lucas" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Bayer" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Ensino E Pesquisa Sao Lucas" #1 collaborator was "Pharmacyclics LLC." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Ensino E Pesquisa Sao Lucas" are "Multiple Myeloma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Instituto de Ensino E Pesquisa Sao Lucas" in a lesser frequency.

Most popular intervention types in "Instituto de Ensino E Pesquisa Sao Lucas" are "Drug" (24 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Prednisone" (4 trials), "Rituximab" (4 trials), "Chlorambucil" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Ensino E Pesquisa Sao Lucas" are 21 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto de Ensino E Pesquisa Sao Lucas". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Instituto de Ensino E Pesquisa Sao Lucas, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Ensino E Pesquisa Sao Lucas, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".